Suchergebnisse - "Kawazoe, Yurika"

PubPharm (24)

1

Comparison design and evaluation power in cohort and self-controlled case series designs for post-authorization vaccine safety studies

enthalten in: PeerJ | 2024

von Sato, S. | Kawazoe, Y. | Katsuta, T. | +1

2

Immune thrombocytopenic purpura and Guillain-Barré syndrome after 23-valent pneumococcal polysaccharide vaccination in Japan : The vaccine effectiveness, networking, and universal safety (VENUS) study

enthalten in: Vaccine | 2024

von Sato, S. | Katsuta, T. | Kawazoe, Y. | +5

3

Effects of the attachment method of the stimulating electrodes Nihon-Kohden NM-345Y™ and changes in forearm position on stimulus current values during calibration in electromyography-based neuromuscular monitoring : a single-center experimental study

enthalten in: Journal of anesthesia | 2023

von Makino, M. | Kaneko, S. | Sato, S. | +5

4

Efficacy and safety of selective JAK 1 inhibitor Filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: Comparative study with Filgotinib and Tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): Study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial

enthalten in: ResearchSquare.com | 2023

von Shimizu, T. | Kawashiri, S. | Morimoto, S. | +8

5

Effectiveness of BNT162b2 against infection, symptomatic infection, and hospitalization among older adults aged ≥65 years during the Delta variant predominance in Japan : The VENUS Study

enthalten in: Journal of epidemiology | 2023

von Mimura, W. | Ishiguro, C. | Terada-Hirashima, J. | +6

6

Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate : comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial

enthalten in: Trials | 2023

von Shimizu, T. | Kawashiri, S. | Morimoto, S. | +8

7

Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial

enthalten in: Trials | 2023

von Shimizu, T. | Kawashiri, S. | Morimoto, S. | +8

8

Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial

enthalten in: Trials | 2023

von Shimizu, T. | Kawashiri, S. | Morimoto, S. | +8

9

A comparative study of the sarcopenia screening in older patients with interstitial lung disease

enthalten in: BMC pulmonary medicine | 2022

von Hanada, M. | Sakamoto, N. | Ishimoto, H. | +12

10

A comparative study of the sarcopenia screening in older patients with interstitial lung disease

enthalten in: BMC pulmonary medicine | 2022

von Hanada, M. | Sakamoto, N. | Ishimoto, H. | +12